Technology

——

EXCYTE LLC is committed to the R&D and industrialization of monoclonal antibody medicines, multi-functional antibody medicines and CAR-T/TCR-T cell immunotherapy.

Product

——

EXCYTE offers antibody hits and leads isolation and screening services to any target of interest chosen by customer

EXCYTE (Beijing) Pharmaceutical Technology Development Co., Ltd.

——

EXCYTE LLC, an institution jointly founded by a number of international experts in the field of biomedicine, is committed to the R&D of multi-functional antibody drugs and CAR-T/TCR-T cell immunotherapy

EXCYTE (Beijing) Pharmaceutical Technology Development Co., Ltd., jointly established by many well-known returned scientists who have worked in the international pharmaceutical companies and research institutions abroad, is in Beijing Zhongguancun Bio-Medicine Park. The company is committed to monoclonal antibody drugs, multi-functional antibody drugs and CAR-T/TCR-T cell immunotherapy research and development and industrialization. The Company maintains close contact and cooperation with many domestic and oversea comprehensive health-related platforms
MORE

Information Center

——

EXCYTE LLC, an institution jointly founded by a number of international experts in the field of biomedicine, is committed to the R&D of multi-functional antibody drugs and CAR-T/TCR-T cell immunotherapy

MORE